Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer

Abstract

Background Colorectal cancer (CRC) screening programs based on fecal immunochemical testing (FIT) generate substantial pressure on colonoscopy capacity in Europe. Thus, a relevant proportion of FIT-positive patients undergo colonoscopy after the recommended 30-day interval, which may be associated with an excess CRC risk.

Methods In a cohort of 50–69-year-old patients undergoing biennial rounds of FIT (OC-Hemodia latex agglutination test; cutoff 20 µg hemoglobin/g feces) between 2004 and 2017, we assessed the outcome at colonoscopy (low/high risk adenoma/CRC/advanced stage CRC) among FIT-positive patients, according to different time intervals. The association of each outcome with waiting time, and demographic and clinical factors, was analyzed through multivariable analysis.

Results 123 138/154 213 FIT-positive patients (79.8 %) underwent post-FIT colonoscopy. Time to colonoscopy was ≤ 30 days, 31–180 days, and ≥ 181 days in 50 406 (40.9 %), 71 724 (58.3 %), and 1008 (0.8 %) patients, respectively. At colonoscopy, CRC, high risk adenoma, and low risk adenoma were diagnosed in 4813 (3.9 %), 30 500 (24.8 %), and 22 986 (18.7 %) patients, respectively. An increased CRC prevalence at colonoscopy was observed for a time to colonoscopy of ≥ 270 days (odds ratio [OR] 1.75, 95 % confidence interval [CI] 1.15–2.67), whereas it was stable for waiting times of < 180 days. The proportion of advanced CRC also increased after 270 days (OR 2.79, 95 %CI 1.03–7.57). No increase for low or high risk adenomas according to time to colonoscopy was observed.

Conclusion In a European FIT-based screening program, post-FIT colonoscopy after 9 months was associated with an increased risk of CRC and CRC progression.

Publication History

Received: 27 December 2019

Accepted: 30 March 2020

Article published online:
30 April 2020

• References

• 1 Chambers K, Whiteman K, Stephens K. et al. Improving inpatient colonoscopy preparation in a university hospital: an evidence-based practice project. Gastroenterol Nurs 2016; 39: 86-94
• 2 Moss S, Mathews C, Day TJ. et al. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England. Gut 2017; 66: 1631-1644
• 3 Hol L, van Leerdam ME, van Ballegooijen M. et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59: 62-68
• 4 Zorzi M, Fedato C, Grazzini G. et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 2011; 60: 944-949
• 5 Zorzi M, Fedeli U, Schievano E. et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut 2015; 64: 784-790
• 6 Zorzi M, Hassan C, Capodaglio G. et al. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test. Gut 2018; 67: 2124-2130
• 7 Zorzi M, Zappa M, AIRTUM WorkingGroup. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates. Gut 2020; 69: 311-316
• 8 Senore C, Basu P, Anttila A. et al. Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report. Gut 2019; 68: 1232-1244
• 9 Corley DA, Jensen CD, Quinn VP. et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA 2017; 317: 1631-1641
• 10 Meester RGS, Zauber AG, Doubeni CA. et al. Consequences of increasing time to colonoscopy examination after positive result from fecal colorectal cancer screening test. Clin Gastroenterol Hepatol 2016; 14: 1445-1451.e8
• 11 Lee Y-C, Fann JC-Y, Chiang T-H. et al. Time to colonoscopy and risk of colorectal cancer in patients with positive results from fecal immunochemical tests. Clin Gastroenterol Hepatol 2019; 17: 1332-1340.e3
• 12 Beshara A, Ahoroni M, Comanester D. et al. Association between time to colonoscopy after a positive guaiac fecal test result and risk of colorectal cancer and advanced stage disease at diagnosis. Int J Cancer 2020; 146: 1532-1540
• 13 European Colorectal Cancer Screening Guidelines Working Group. . European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013; 45: 51-59
• 14 Zorzi M, Barca A, Falcini F. et al. Screening for colorectal cancer in Italy: 2005 survey. Epidemiol Prev 2007; 31: 49-60
• 15 Brenner H, Altenhofen L, Stock C. et al. Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev 2013; 22: 1043-1051